Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Nicotine Treatment of Mild Cognitive Impairment (MCI)
This study is ongoing, but not recruiting participants.
Study NCT00091468 Information provided by National Institute on Aging (NIA)
First Received: September 9, 2004 Last Updated: January 7, 2008
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Age-Related Memory Disorders
Additional conditions recognized in this trial
Cognition Disorders
Memory Disorders
More general conditions related to this trial
Delirium, Dementia, Amnestic, Cognitive Disorders
Mental Disorders
Nervous System Diseases
Neurobehavioral Manifestations
Neurologic Manifestations
Signs and Symptoms
Interventions listed in this trial
Transdermal nicotine patch
Placebo transdermal patch
Additional drug interventions recognized in this trial
Nicotine
Nicotine polacrilex
More general drug interventions related to this trial
Autonomic Agents
Central Nervous System Agents
Central Nervous System Stimulants
Cholinergic Agents
Cholinergic Agonists
Ganglionic Stimulants
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Nicotinic Agonists
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
National Institute on Aging (NIA)
Back to top of Main Content
